Wilky, B. A., Schwartz, G. K., Gordon, M. S., El-Khoueiry, A. B., Bullock, A. J., Henick, B., Agulnik, M., Singh, A., Mahadevan, D., Stebbing, J., Delepine, C., Chand, D., Avagyan, M., Wu, W., Johnson, B., Grossman, J. E., O’Day, S., Trent, J. C., Jones, R. L., & Tsimberidou, A. M. (2025). Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02524